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Abstract 
Purpose: Pancreatic triacylglycerol lipase (PL) is a noteworthy pharmacological target for the 
management of dyslipidemia, and diabetes and obesity. This study was aimed to evaluate the 
modulatory effects of Salvia triloba L.f. (Lamiaceae) leaves methanol extract (ME) on a high fat diet 
(HFD)-induced hypertriglyceridemia in rats, with complementary in vitro evaluation of sage PL-inhibitory 
potential.  
Methods: Pre-induction of HFD hypertriglyceridemia sage leaves ME (750 mg/kg) was orally 
supplemented (via gastric intubation) to overnight fasting rats (n = 5).  Potential plant modulation of PL 
was also quantified in vitro by a colorimetric assay (n = 3).   For comparison, the effect of Orlistat was 
similarly evaluated as reference standard. 
Results: Compared to Orlistat, supplementation of S. triloba at a dose of 750 mg/kg b.wt significantly 
reversed the HFD-induced postprandial hypertriglyceridemia in experimental overnight fasting rats (p < 
0.001 vs. HFD rats). Dietary sage caused 66.4 % reduction in plasma triglycerides. Compared to 
Orlistat which exerted antilipolytic activity, with half-maximal inhibitory concentration (IC50) of 0.114 ± 
0.004 µg/mL), sage inhibited PL activity in vitro in a dose-dependent manner IC50 of 100.80 ± 9.07 
µg/mL)  
Conclusion: Sage has dual hypotriglyceridemic and antilipolytic properties which indicate that it can 
potentially be used to suppress body weight gain. 
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Obesity and its cardiovascular comorbidities 
have increasingly become an alarming public 
health concern despite the remarkable progress 
in the discovery and development of novel 
obesity-diabetes therapeutics. For many years, 
plant-derived compounds have been at the 
forefront as important sources of 
phytotherapeutic and/or preventive agents due to 
plants' availability and relatively high safety [1,2]. 
Salvia as one of the largest genera in the family 
Lamiaceae is represented by more than 900 
species. Several Salvia species are closely 
linked to Jordanian traditional medicine in the 
treatment of multiple ailments [3,4]. Sage (Salvia 
triloba L.f.) specifically is a medicinal plant widely 
used in Jordan both as a folk remedy and in the 
food and beverage industry [5].  
 
Pancreatic lipase (PL) is a key enzyme for lipid 
breakdown that is necessary for the absorption of 
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dietary lipids [6]. The success of 
tetrahydrolipstatin (orlistat) which is a specific 
pancreatic lipase inhibitor has prompted research 
to identify new pancreatic lipase inhibitors 
derived from natural sources [7-9].  Natural 
compounds, like berberine, dihydroberberine and 
curcumin have substantially been proven as PL-
inhibitors [10-11]. Phytochemically, the 
pentacyclic triterpenes, oleanolic acid and ursolic 
acid in S. triloba are established as attractive 
constituents with PL modulatory activities [12,13]. 
As a continuation of our interest in the 
phytoprinciples-based PL inhibitors with 
hypotriglyceridemic efficacies, the present study 
was designed to determine the in vivo 
postprandial plasma triglycerides lowering 
properties of S. triloba crude methanol extracts in 
high fat fed animals and the complementary 
investigation of its in vitro PL-inhibition 
capacities. For comparison, the effect of orlistat 




Chemicals and instruments 
 
Unless otherwise stated, all reagents and 
chemicals of analytical grade were procured from 
Sigma® (Dorset, UK). In the UV determinations, 
a UV-VIS spectrophotometer from SpectroScan® 
80D (UK) was used. Reference drugs were 
purchased from local suppliers. 
 
Plant collection and extraction 
 
Aerial parts of Salvia triloba (sage) were 
procured from Amman, Jordan in the summer of 
2014. Taxonomic identification of the plant was 
carried out by Professor Khaled Tawaha 
(Department of Pharmaceutical Sciences, 
Faculty of Pharmacy, University of Jordan) and a 
voucher specimen deposited in the herbarium. 
Sage leaves were dried for three days and then 
ground into a fine powder. In a Soxhlet apparatus 
(Sigma-Aldrich, USA), the powder was 
subsequently extracted with absolute methanol 
for 72 h. The solvent was afterwards filtered and 
then evaporated using Rotavapor (Laborota 
4000-efficient, Heidolph, Germany). The extract 
obtained was further left at 24 ± 0.5 ºC for 24 h in 
order to allow for complete drying and then 
stored in a refrigerator until used. 
 
Preparation of S. triloba ME and orlistat for in 
vitro PL activity assay 
 
Sage methanol extracts were initially dissolved in 
a Tris-HCl buffer (2.5 mM [Promega®, USA], pH 
7.4 with 2.5 mM NaCl) to give five initial stock 
solutions with a concentration range of 0.3125 – 
10.0 mg/mL. Subsequently, a 20 μL aliquot of 
each stock solution was used in the reaction 
mixture to give a final concentration range of 
6.25 – 200 μg/mL. Extracts were prepared 
according to traditional use, so DMSO or any 
other organic solvent, even in a minimum 
concentration, was avoided [14].  
 
Finally, orlistat, the reference drug (Hayat 
Pharmaceutical Industries Co. PLC, Jordan; 1 
mg/mL DMSO), was prepared into six different 
stock solutions with a concentration range of 
0.625 - 20 µg/ mL. Thereafter, a 20 μL aliquot of 
each stock solution was used in the reaction 
mixture to give a final concentration range of 
0.0125 – 0.4 μg/mL. 
 
Spectrophotometric quantification of PL 
inhibition by test extracts and orlistat 
 
Pancreatic lipase activity was determined by 
measuring the rate of release of p-Nitrophenol 
(p-NP) from p-Nitrophenol butyrate (p-NPB). 
Enzyme assay was conducted by the 
spectrophotometric method as per the protocol 
from Al-Hallaq et al [8-9] and Bustanji et al [15]. 
Subsequent determinations were undertaken for 
the tested extracts and orlistat (n = 3) to 
calculate the concentration required for the PL 50 




All experiments related to diet-induced lipid 
profile derangements (hypertriglyceridemia) were 
conducted with male Albino rats at the 
experimental animal laboratory at the University 
of Jordan. All animal experiments comply with 
the Guide for the Care and Use of Laboratory 
Animals 8th edition published by the US   
National Institute of Health [16,17].  
 
The ethical approval for conducting animal 
studies was obtained from the ethical and 
scientific research council at the faculty of 
Pharmacy/ the University of Jordan (Ref No. 
27/2/2010/3). Before the investigations, rats 
initially weighing 375 - 425 g (average 400 g) 
were housed in groups of five per cage with free 
access to tap water and proper pellet chow ad 
libitum at 25 ± 0.5 ºC with a relative humidity 50 
– 60 % and a 12 h light/dark cycle [16].  
 
As the acute oral toxicity studies were performed 
in overnight fasting animals, no abnormal 
behavior or mortality was evidenced at the sage 
dose range of 500 – 1000 mg/kg b.wt. Hence, 
the dose 750 mg/kg b.wt was selected as the 
therapeutic/preventive dose in the present study. 
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Overnight fasting rats were randomly divided into 
4 groups with 5 animals each, assigned to:  
 
Group I – Normal diet control (standard rat chow) 
 
Group II – High fat (30%) diet (HFD) control [18] 
 
Group III – Orlistat (5 mg/kg b.wt) + HFD 
 
Group IV – Sage ME (750 mg/kg b.wt) + HFD 
 
Except for group I, overnight fasting male Albino 
rats were fed a HFD following an initial 
supplementation with 1 mL of vehicle (20 % 
ethanol + 80 % water; group II), orlistat (5 mg/kg 
b.wt; group III), or sage ME (750 mg/kg b.wt; 
group IV) as per assigned to treatment groups 
via gastric intubation. Tail vein blood samples 
were collected under ether anesthesia and 
subsequently centrifuged for 5 min at 4000 rpm 
(round per minute). 
 
Using an enzymatically commercial kit (Joaquim 
Costa®, Barcelona, Spain), postprandial HFD 
induced changes in plasma triglycerides were 




Data are represented as mean ± standard 
deviation (SD, n = 3 – 5). Statistical differences 
between the control and different treatment 
groups were determined with Graphpad Prism® 
(version 3.02 for Windows; GraphPad Software, 
San Diego, CA, USA) using one way analysis of 
variance (ANOVA) followed by Newman Keuls’ 
post test whenever appropriate. Values were 
considered significantly different if p < 0.05, and 





Inhibitory effect of S. triloba ME on PL activity  
 
The IC50 of Orlistat was 114.0 ± 4.0 ng/mL 
(equivalent to 0.2 ± 0.0 μM, n = 3). Compared to 
orlistat, a marked concentration-dependent PL 
inhibition trend was obtained from the S. triloba 
tested extracts. The inhibitory profiles of S. 
triloba leaves ME are shown in Figure 1. The IC50 
of sage value obtained for a minimum of triple 
independent determinations was 100.8 + 9.07 
μg/mL. 
 
Effect of sage on postprandial plasma 
triglycerides in HFD rats 
 
A promising hypotriglyceridemic influence of 
dietary sage at 750 mg/kg is observed in HFD-
induced hypertriglyceridemic rats. Figure 2 
demonstrates the effect of dietary S. triloba ME 
(750 mg/kg) on plasma triacylglyceride levels. 
Expectedly, plasma triglycerides (mg/dL) in HFD-
fed animals are highly significantly greater than 
those in the control rats (217.8 ± 81.92 vs. 62.8 ± 
14.53 respectively, n = 5 rats/group, p < 0.001, 
Figure 2). 
 
Figure 1: In vitro inhibitory effects of ascending concentrations (µg/mL) of S. triloba ME and orlistat on pancreatic 
triacylglycerol lipase activity. Results are mean ± SD (n = 3 independent replicates) 
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Figure 2: In vivo effects of dietary S. triloba ME (750 mg/kg b.wt) on postprandial hypertriglyceridemia in HFD-fed 
animals (n = 5). Results are expressed as mean ± SD of plasma triacylglycerides using ANOVA followed by 
Newman Keuls' post-test where ***P<0.001 compared to normal diet control group, ∆∆∆P<0.001 compared to HFD 
group 
 
In orlistat- treated HFD-fed rats (group III), 
plasma triglycerides (mg/dL) are substantially 
less than those in untreated HFD-fed rats (68.1 ± 
24.8 vs. 217.8 ± 81.9 respectively, n = 5 
rats/group, p < 0.001, Figure 2) with a 68.8 % 
reduction. Also, postprandial hypertriglyceridemia 
(mg/dL) has been impressively normalized in 
group III as in the controls’ (68.1 ± 24.8 vs. 62.8 
± 14.53 respectively, n = 5 rats/group, p > 0.05). 
Similarly, in the S. triloba 750 mg/kg b treated 
HFD-fed rats (group IV), plasma triglycerides 
(mg/dL) are highly markedly less than in those in 
HFD-fed animals (73.2 ± 36.8 vs. 217.8 ± 81.92 
respectively, n = 5 rats/group, p < 0.001) with a 
66.4 % reduction. Postprandial plasma 
triglycerides in group IV are comparable to 
controls' (73.2 ± 36.8 vs. 62.8 ± 14.53 
respectively, n = 5 rats/group, p > 0.05) and 
orlistat-treated HFD animals' (73.2 ± 36.8 vs. 
68.1 ± 24.77, n = 5 rats/group, p > 0.05). Taken 
together, these outcomes are perfectly aligned 




Potential anti-obesity pharmacotherapeutics 
were intensely scrutinized as obesity was 
reaching alarming epidemic proportions globally 
[19]. Pharmacological intervention with natural 
product-based drugs is an effective and safe 
alternative for mitigating obesity. Pancreatic 
triacylglycerol lipase (PL) is an interesting 
pharmacological target for the management of 
dyslipidemia, atherosclerosis, and obesity-related 
dyslipidemia [19-21]. The orlistat PL-IC50 value 
obtained in this current study is comparable to 
the other reported PL-IC50 values [20]. These 
significant anti-lipase effects of sage may be 
solidly related to the effect of the major 
compounds identified in the crude extract [8,20] 
acting additively or synergistically in optimal ratio 
[22]. Hydrocarbons, sterols, triterpenes, fatty 
acids, phenolic acids, and flavonoids have been 
identified in S. triloba. Salvia species [23-25]. 
The presence of pentacyclic triterpenes 
(oleanolic acid, carnosic acid, and ursolic acid) in 
Salvia species may account for the plant PL 
inhibitory propensities [26-29]. All in all, 
pharmacological inhibition of dietary lipid 
digestion and absorption may induce favorable 
amelioration of dyslipidemia, atherosclerosis, and 
obesity. Impressively, pancreatic triacylglycerol 
lipase natural inhibitors offer the utility for 
adjuvant or alternative treatment to statins or 
orlistat as likely synergies can exist between new 
and established lipid-lowering drugs [30]. 
 
In a study performed by Mnafgui et al [31], it was 
found that the inhibitory action of PL leads to a 
decrease in lipid profiles. Our in vitro and in vivo 
findings combined are in agreement with those of 
Mnafgui et al [31]. As the occurrence of obesity is 
on the rise, various recent studies have been 
done regarding the treatment of obesity through 
the suppression of triglyceride accumulation by 
inhibiting the digestion of dietary lipids. This may 
minimize intestinal fat absorption with a 
remarkable body weight reducing influence 




Sage extract can inhibit crucial gastrointestinal 
enzymes involved in lipid digestion and 
absorption, which indicates that sage is a 
potential phytotherapeutic/prophylactic strategy 
to control obesity-associated 
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hypertriglyceridemia. Future studies would focus 
on the in vitro and in vivo testing of therapeutic 
and/or preventive potentials of sage extract both 
alone and in combination with established 
pharmacological and natural agents used for the 
management of adiposity-related dyslipidemia 
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